Diabetes mellitus patients with increased death rates and clinical complications in patients with CoV-19 pneumonia: A systematic review
Abstract
Diabetes Mellitus (DM) is a chronic condition that has been associated with Corona virus (CV) sickness and has the potential to cause catastrophic multisystemic consequences. They used a complete meta-analysis and review to examine the connection among DM and a bad prognosis in COVID-19 pneumonia individuals. We searched many online databases for articles assessing the correlation between DM and outcome in COVID-19 pneumonia. This study's principal result was an undesirable interaction of three secondary results: the occurrence of severe cardiovascular disease (CVD), acute respiratory distress syndrome (ARDS), and death. All 17 studies had 6452 participants. After eliminating the duplicates, the number of records remained at 350. After first looking at the titles and abstracts, we discarded 310 articles. After reviewing 43 full-text publications, 13 were ruled ineligible owing to a lack of mortality, interest, or disease progression outcomes, including those for severe ARDS which is disease progression, ARDS, Mortality and COVID-19 severity, were increased in COVID-19 patients with DM.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 6,452 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.